Canopy Growth: Is Another Reverse Stock Split Inevitable?

Canopy Growth (CGC) may need another reverse stock split to stay compliant with Nasdaq’s $1 minimum price rule after trading back below $1 and risking a delisting notification if it remains there for 30 consecutive business days. The last 1-for-10 reverse split occurred in December 2023, but the stock is down about 80% since then, reflecting persistently poor financial results and continued losses.

Analysis

This is less about the corporate action itself than about the financing regime it signals. A reverse split can temporarily improve optics, but it does not repair the core problem: when a micro-cap equity is perpetually below the listing threshold, management is usually one step away from using a higher nominal share price to reopen dilution capacity. That tends to raise the equity risk premium, widen bid/ask spreads, and keep long-only capital on the sidelines.

The second-order effect is sector contamination: serial distress at one operator reinforces the market’s willingness to discount the entire cannabis complex on cash burn and funding risk rather than on headline growth. Relative winners are the better-capitalized names and any cannabis basket with balance-sheet support; relative losers are the weakest balance-sheet operators that now have a higher hurdle to access equity capital on acceptable terms. If CGC follows with a financing, the split will have been a prelude to dilution, not a solution.

The contrarian setup is a tactical squeeze into a split announcement because retail/speculative flows often chase a higher post-split price. That trade is usually short-lived unless there is a verifiable inflection in cash burn, gross margin, or working capital. The key falsifier is not the share count adjustment; it is whether CGC can avoid another equity raise over the next 1-3 quarters without sacrificing liquidity.

Key Decisions for Investors

• Short CGC on any pre-announcement strength or into a formal reverse-split/compliance headline; treat this as a 1-3 week tactical trade, not a long-term hold. Cover into the event-driven spike if it occurs, because the upside squeeze can be violent but typically fades.
• If borrow is too costly or unstable, use 3-6 month CGC put spreads instead of outright short stock. The risk/reward is best if the market anticipates a reverse split followed by dilution or a financing package.
• Pair trade: long a stronger cannabis balance-sheet proxy (TLRY or SNDL) versus short CGC for a relative-quality expression over 1-3 months. This isolates financing risk and reduces exposure to broad sector beta.
• Avoid chasing any post-split nominal-price bounce unless management simultaneously improves cash burn or extends runway without dilution. The thesis is falsified if CGC regains and holds above $1 for 30+ trading days without a financing overhang.